曼月乐联合妈富隆在子宫腺肌症药物治疗中的应用

《曼月乐联合妈富隆在子宫腺肌症药物治疗中的应用》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、曼月乐联合妈富隆在子宫腺肌症药物治疗中的应用【摘要】H的分析左炔诺孕酮宫内节育系统（曼月乐）联合去氧孕烯炔雌醇片（妈富隆）在子宫腺肌症药物治疗中的疗效。方法75例子宫腺肌症患者（已婚已育不愿手术），按照入院治疗的时间随机分为A、B、C组，各25例。A组给予单独应用曼月乐治疗，B组单独应用妈富隆药物治疗，C组给予曼月乐联合妈富隆治疗，对比三组女性患者治疗的效果。结果C组治疗后痛经评分、子宫体积、子宫内膜厚度及血清CA125水平明显优于A组和B组，差异有统计学意义（P〈0.05）。C组治疗总有效率高达96.00%,明显高于A组的76.00%和B组的72.00%，差异有统计学意义（P

2、〈0.05）。C组阴道出血发生率4.00%与A组的16.00%和B组的8.00%比较差异无统计学意义（P〈0.05）；C组脱环发生率为0与A组的8.00%和B组的比较差异无统计学意义（P〉0.05）。结论曼月乐联合妈富隆在治疗子宫腺肌症具有起效快、安全性高、不影响妊娠、无创伤、并发症少等众多的优点，故该种治疗方法值得临床推广及借鉴。本文采集自网络，本站发布的论文均是优质论文，供学习和研究使用，文中立场与本网站无关，版权和著作权归原作者所右，如存不愿意被转载的情况，请通知我们删除己转载的信息，如果需要分享，请保留本段说明。【关键词】左炔诺孕酮宫内节育系统；去氧孕烯炔雌醇片；子宫腺

3、肌症；效果DOI：10.14163/j.cnki.11-5547/r.2017.04.046[Abstract]ObjectiveToanalyzethecurativeeffectoflevonorgestrel-releasingintrauterinesystem(Mirena)combinedwithdesogestrelandethinylestradioltablet(Marvelon)indrugtherapyofadenomyosis.MethodsAtotalof75adenomyosisfemalepatients(marriedwithchildrenan

4、ddonotwantsurgery)weredividedbyadmissionorderintogroupA,groupBandgroupC，with25casesineachgroup.GroupAreceivedMarvelonalonefortreatment,groupBreceivedMarvelonalonefortreatment,andgroupCreceivedMirenacombinedwithMarvelonfortreatment.Treatmenteffectswerecomparedinthreegroups.ResultsGroupChadobv

5、iouslybetterdysmenorrheascore,uterinevolume,endometrialthicknessandserumCA125levelaftertreatmentthangroupAandgroupB,andtheirdifferenceshadstatisticalsignificance(P〈0.05).GroupChadtotaltreatmenteffectiverateas96.00%,whichwasobviouslyhigherthan76.00%ingroupAand72.00%ingroupB,andtheirdifference

6、hadstatisticalsignificance(P<0.05).GroupChadincidenceofvaginalbleedingas4.00%,whichwashadnostatisticalsignificance(P>0.05)；GroupChaddecyclizationrateas0，whichwas8.00%ingroupAand0ingroupB,andtheirdifferencehadnostatisticallysignificantdifference(P>0.05).ConclusionMirenacombinedwithMarvelonhad

7、advantagesofquickeffect,highsafety,withoutaffectingthepregnancy,notrauma,fewercomplicationsinthetreatmentofadcnomyosis,sothistreatmentmethodisworthclinicalpromotionandreference.【Keywords］Levonorgestrel-releasingintrauterinesystem；Desogestrelandethi